Skip to main content
. 2005 Jan 24;144(5):651–659. doi: 10.1038/sj.bjp.0706087

Table 2.

Column A shows the amounts of receptors (Bmax) in membrane preparations from COS-7 and Neuro2A cells after transient transfection with the wt α1D-adrenoceptor (wt), and with the signal peptide-supplemented α1D-adrenoceptor (SP)

Transient expression in COS-7 or Neuro2A cells of wt and signal peptide-supplemented α1D-AR A. Bmax receptors (fmol mg−1 protein) B. Bmax receptors (% compared to wt) C. pKd [3H]-prazosin n
α1D-AR (wt) COS-7 69.3±6.4 100 9.93±0.10 4
α1D-AR (SP) COS-7 838±200 1190±220 9.83±0.07 4
α1D-AR (wt) Neuro2A 103±31 100 10.13±0.07 4
α1D-AR (SP) Neuro2A 1120±80 1300±240 9.90±0.09 4

Column B shows Bmax of the signal peptide-supplemented α1D-AR (SP) in percent of that of the wild type α1D-AR (wt), from experimentally paired plates. Column C shows the pKd values of [3H]-prazosin for the receptors.